Pembrolizumab and Cabozantinib in patients with Recurrent Metastatic Head and Neck Squamous Cell Carcinoma
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP409002
下载链接
链接失效反馈官方服务：
资源简介：
We conducted a phase II multicenter single arm trial of pembrolizumab and cabozantininb in patients with Recurrent Metastatic Head and Neck Squamous Cell Carcinoma). We extracted DNA from 16 tumors and 4 germline DNA as a control and performed whole genome sequencing to determine tumor mutation burden (TMB). The TMB was associated with response data.
创建时间：
2023-04-03
